A F Kirkin - JoVE Visualize

Showing results (21-30 of 34) with videos related to

Pageof 4

Sort By:

Biulleten' Eksperimental'Noi Biologii I Meditsiny|April 1, 1981

[Description of the effect of polyclonal mitogens on a population of splenic lymphocytes in the presence of serum against isologous aggregated mouse immunoglobulins]V V Khorobrykh, O S Merimskaia, A E Snegireva, et al.

Cancer Research|December 1, 1996

The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesisJ Bartkova, J Lukas, P Guldberg, et al.

Cancer Immunology, Immunotherapy : CII|September 9, 1999

Establishment of gp100 and MART-1/Melan-A-specific cytotoxic T lymphocyte clones using in vitro immunization against preselected highly immunogenic melanoma cell clonesA F Kirkin, P thor Straten, M R Hansen, et al.

International Journal of Cancer|March 12, 1998

Generation and characterization of gp100 peptide-specific NK-T cell clonesI Saeterdal, P thor Straten, J H Myklebust, et al.

Cancer Immunology, Immunotherapy : CII|August 1, 1995

Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell linesA F Kirkin, T R Petersen, A C Olsen, et al.

Journal of Experimental & Clinical Cancer Research : CR|August 22, 2006

Vaccination with melanoma lysate-pulsed dendritic cells, of patients with advanced colorectal carcinoma: report from a phase I studyS K Burgdorf, A Fischer, M H Claesson, et al.

Cancer Research|August 1, 1997

Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3T Halder, G Pawelec, A F Kirkin, et al.

Scandinavian Journal of Immunology|January 29, 2000

Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells In vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 proteinA M Barfoed, T R Petersen, A F Kirkin, et al.

Immunology Letters|January 1, 1992

Synthetic peptide with antiproliferative activity: a short C-terminal fragment of the human interferon alpha-2 moleculeA V Danilkovich, K V Freze, A F Shevalier, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000

Amino acid substitutions in the melanoma antigen recognized by T cell 1 peptide modulate cytokine responses in melanoma-specific T cellsM B Nielsen, A F Kirkin, D Loftus, et al.

Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:

Pageof 4

Biulleten' Eksperimental'Noi Biologii I Meditsiny|April 1, 1981

[Description of the effect of polyclonal mitogens on a population of splenic lymphocytes in the presence of serum against isologous aggregated mouse immunoglobulins]V V Khorobrykh, O S Merimskaia, A E Snegireva, et al.

Cancer Research|December 1, 1996

The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesisJ Bartkova, J Lukas, P Guldberg, et al.

Cancer Immunology, Immunotherapy : CII|September 9, 1999

Establishment of gp100 and MART-1/Melan-A-specific cytotoxic T lymphocyte clones using in vitro immunization against preselected highly immunogenic melanoma cell clonesA F Kirkin, P thor Straten, M R Hansen, et al.

International Journal of Cancer|March 12, 1998

Generation and characterization of gp100 peptide-specific NK-T cell clonesI Saeterdal, P thor Straten, J H Myklebust, et al.

Cancer Immunology, Immunotherapy : CII|August 1, 1995

Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell linesA F Kirkin, T R Petersen, A C Olsen, et al.

Journal of Experimental & Clinical Cancer Research : CR|August 22, 2006

Vaccination with melanoma lysate-pulsed dendritic cells, of patients with advanced colorectal carcinoma: report from a phase I studyS K Burgdorf, A Fischer, M H Claesson, et al.

Cancer Research|August 1, 1997

Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3T Halder, G Pawelec, A F Kirkin, et al.

Scandinavian Journal of Immunology|January 29, 2000

Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells In vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 proteinA M Barfoed, T R Petersen, A F Kirkin, et al.

Immunology Letters|January 1, 1992

Synthetic peptide with antiproliferative activity: a short C-terminal fragment of the human interferon alpha-2 moleculeA V Danilkovich, K V Freze, A F Shevalier, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000

Amino acid substitutions in the melanoma antigen recognized by T cell 1 peptide modulate cytokine responses in melanoma-specific T cellsM B Nielsen, A F Kirkin, D Loftus, et al.

Pageof 4